Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that individuals with a rare genetic disorder linked to the AEBP1 gene may experience a unique type of hair loss and should be monitored for heart issues.

COVID-19 can cause significant hair loss.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Skin cells produce and activate vitamin D, which regulates skin functions and supports hair growth.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The new biomaterial inspired by ancient Chinese medicine effectively promotes hair growth and heals wounds in burned skin.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Synthetic cannabinoid addiction can cause skin problems like acne and hair loss.

Finasteride does not prevent bladder cancer.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

The new gel improves skin delivery of a drug, potentially reducing dose frequency and side effects.

Platelet-rich plasma can potentially improve hair regeneration by increasing follicular gene expression and hair growth activity.

Inhalation therapy may repair and protect elastin in the lungs of COPD patients.

Dermal EZH2 controls skin cell development and hair growth in mice.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Estradiol may protect ear cells from hearing loss caused by a chemotherapy drug by activating a protective pathway.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

The herbal mixture could potentially improve hair loss.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.